SMOLDERING PLASMA CELL MYELOMA
Clinical trials for SMOLDERING PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new SMOLDERING PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for SMOLDERING PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common arthritis drug hold off a rare blood cancer?
Disease control OngoingThis phase 2 trial is testing whether leflunomide, a drug used for arthritis, can delay the onset of multiple myeloma in 27 people with high-risk smoldering multiple myeloma. The study includes both African-American and European-American participants to see if the drug works diff…
Matched conditions: SMOLDERING PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New drug duo aims to stop smoldering myeloma from becoming full-blown cancer
Disease control OngoingThis study tests whether the drug isatuximab, given alone or with lenalidomide, can control or shrink the signs of smoldering multiple myeloma in people at high risk of developing active disease. About 61 participants receive the treatment to see if it delays progression and impr…
Matched conditions: SMOLDERING PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can keytruda stop smoldering myeloma in its tracks?
Disease control OngoingThis early-phase trial is testing the immunotherapy drug pembrolizumab (Keytruda) in 20 people with smoldering multiple myeloma at intermediate or high risk of progression. The goal is to see if the drug can shrink the cancer or delay it from becoming active multiple myeloma. Res…
Matched conditions: SMOLDERING PLASMA CELL MYELOMA
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a common arthritis drug slow down multiple myeloma?
Disease control OngoingThis early-phase trial tested leflunomide, an anti-inflammatory drug, in one patient with high-risk smoldering multiple myeloma. The goal was to see if the drug could delay progression to active myeloma. The study focused on safety and disease activity, but results are limited du…
Matched conditions: SMOLDERING PLASMA CELL MYELOMA
Phase: EARLY_PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC